Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

SOR GENE FROM HUMAN IMMUNODEFICIENCY VIRUS

  • Read more about SOR GENE FROM HUMAN IMMUNODEFICIENCY VIRUS
US Application 07/138,530
Filed on 1987-12-28

EFFICIENT METHOD FOR IDENTIFIABLE EXPRESSION OF NONSELECTABLE GENES

  • Read more about EFFICIENT METHOD FOR IDENTIFIABLE EXPRESSION OF NONSELECTABLE GENES
US Application 07/871,608
Filed on 1992-04-20

PACKAGING DEFECTIVE DELETION MUTANT OF HTLV-III

  • Read more about PACKAGING DEFECTIVE DELETION MUTANT OF HTLV-III
US Application 07/032,115
Filed on 1987-03-30

METHOD FOR DESIGNING CANCER TREATMENT REGIMENS AND METHODS AND PHAR- MACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER

  • Read more about METHOD FOR DESIGNING CANCER TREATMENT REGIMENS AND METHODS AND PHAR- MACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
US Application 07/880,525
Filed on 1992-05-08

METHOD FOR TREATING MALIGNANCY AND AUTOIMMUNE DISORDERS IN HUMANS

  • Read more about METHOD FOR TREATING MALIGNANCY AND AUTOIMMUNE DISORDERS IN HUMANS
US Application 07/879,056
Filed on 1992-04-30

USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY

  • Read more about USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
US Application 07/882,223
Filed on 1992-05-13

HIV NUCLEOCAPSID PROTEIN CAPTURE ASSAY AND METHOD OF USE

  • Read more about HIV NUCLEOCAPSID PROTEIN CAPTURE ASSAY AND METHOD OF USE
US Patent 5,462,852
Filed on 1992-10-28

ACID STABLE PURINE DIDEOXYNUCLEOSIDES ACTIVE AGAINST CYTOPATHIC EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS

  • Read more about ACID STABLE PURINE DIDEOXYNUCLEOSIDES ACTIVE AGAINST CYTOPATHIC EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS
US Patent 5,495,010
Filed on 1991-09-19

INHIBITORS FOR REPLICATION FOR RETROVIRUSES AND FOR THE EXPRESSION OF ONCOGENE PRODUCTS

  • Read more about INHIBITORS FOR REPLICATION FOR RETROVIRUSES AND FOR THE EXPRESSION OF ONCOGENE PRODUCTS
US Patent 5,286,717
Filed on 1992-11-16

EPITHELIAL CELL SPECIFIC DIFFERENTIATION MARKER

  • Read more about EPITHELIAL CELL SPECIFIC DIFFERENTIATION MARKER
US Patent 5,424,191
Filed on 1992-05-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1614
  • Page 1615
  • Page 1616
  • Page 1617
  • Page 1618
  • Page 1619
  • Page 1620
  • Page 1621
  • Page 1622
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health